[HTML][HTML] Relationship between amyloid-β deposition and blood–brain barrier dysfunction in Alzheimer's disease
D Wang, F Chen, Z Han, Z Yin, X Ge… - Frontiers in Cellular …, 2021 - frontiersin.org
Amyloid-β (Aβ) is the predominant pathologic protein in Alzheimer's disease (AD). The
production and deposition of Aβ are important factors affecting AD progression and …
production and deposition of Aβ are important factors affecting AD progression and …
[HTML][HTML] Small-molecule theranostics in Alzheimer's disease
Á Sarabia-Vallejo, P López-Alvarado… - European Journal of …, 2023 - Elsevier
Alzheimer's Disease (AD) remains one of the most challenging health-related issues for our
society, that is becoming increasingly prevalent, especially in developed countries, due to …
society, that is becoming increasingly prevalent, especially in developed countries, due to …
[HTML][HTML] Aβ plaques
LC Walker - Free neuropathology, 2020 - ncbi.nlm.nih.gov
Aβ plaques are one of the two lesions in the brain that define the neuropathological
diagnosis of Alzheimer's disease. Plaques are highly diverse structures; many of them …
diagnosis of Alzheimer's disease. Plaques are highly diverse structures; many of them …
Mangosteen pericarp and its bioactive xanthones: Potential therapeutic value in Alzheimer's disease, Parkinson's disease, and depression with pharmacokinetic and …
HTT Do, J Cho - International journal of molecular sciences, 2020 - mdpi.com
Alzheimer's disease (AD), Parkinson's disease (PD), and depression are growing burdens
for society globally, partly due to a lack of effective treatments. Mangosteen (Garcinia …
for society globally, partly due to a lack of effective treatments. Mangosteen (Garcinia …
Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease
Significance: Reactive oxygen species (ROS) are crucial signaling molecules in the
regulation of numerous physiological activities including the formation and function of the …
regulation of numerous physiological activities including the formation and function of the …
[HTML][HTML] Contribution of A-to-I RNA editing, M6A RNA Methylation, and Alternative Splicing to physiological brain aging and neurodegenerative diseases
V Tassinari, P La Rosa, E Guida, A Colopi… - Mechanisms of ageing …, 2023 - Elsevier
Aging is a physiological and progressive phenomenon in all organisms' life cycle,
characterized by the accumulation of degenerative processes triggered by several …
characterized by the accumulation of degenerative processes triggered by several …
Precision medicine through antisense oligonucleotide-mediated exon skipping
Clinical implementation of two recently approved antisense RNA therapeutics–Exondys51®
to treat Duchenne muscular dystrophy (Duchenne MD) and Spinraza® as a treatment for …
to treat Duchenne muscular dystrophy (Duchenne MD) and Spinraza® as a treatment for …
Nanoparticles-assisted aptamer biosensing for the detection of environmental pathogens
Given the importance of public health, it is crucial to develop quick, targeted, highly
sensitive, and accurate technologies to monitor pathogenic microbes in response to the …
sensitive, and accurate technologies to monitor pathogenic microbes in response to the …
[HTML][HTML] Aptamer-engineered (nano) materials for theranostic applications
A diverse array of organic and inorganic materials, including nanomaterials, has been
extensively employed in multifunctional biomedical applications. These applications …
extensively employed in multifunctional biomedical applications. These applications …
Innovative therapies and nanomedicine applications for the treatment of Alzheimer's disease: a state-of-the-art (2017–2020)
A Binda, C Murano, I Rivolta - International Journal of …, 2020 - Taylor & Francis
The field of nanomedicine is constantly expanding. Since the first work dated in 1999, almost
28 thousand articles have been published, and more and more are published every year …
28 thousand articles have been published, and more and more are published every year …